• Publications
  • Influence
Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving 225Ac-PSMA-617 Radioligand Therapy
Metastatic prostate carcinoma overexpresses prostate-specific membrane antigen (PSMA), making this antigen a suitable target for radioligand therapy of the disease. Here we report on our experienceExpand
Intraindividual Comparison of 18F-PSMA-1007 and 18F-DCFPyL PET/CT in the Prospective Evaluation of Patients with Newly Diagnosed Prostate Carcinoma: A Pilot Study
The introduction of 18F-labeled prostate-specific membrane antigen (PSMA)–targeted PET/CT tracers, first 18F-DCFPyLExpand
68Ga‐PSMA PET/CT Replacing Bone Scan in the Initial Staging of Skeletal Metastasis in Prostate Cancer: A Fait Accompli?
Micro‐Abstract We compared the findings of technetium‐99m–10‐metacyloyloxydecyl dihydrogen phosphate (99mTc‐MDP) bone scintigraphy and 68Ga–prostate‐specific membrane antigen (PSMA) positron emissionExpand
225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study
BackgroundA remarkable therapeutic efficacy has been demonstrated with 225Ac-prostate-specific membrane antigen (PSMA)-617 in heavily pre-treated metastatic castration-resistant prostate cancerExpand
Arterial inflammation in young patients with human immunodeficiency virus infection: A cross-sectional study using F-18 FDG PET/CT
BackgroundHIV infection is associated with the risk of development of atherosclerosis at a younger age. We compared arterial inflammation in HIV-infected and HIV-uninfected patients with otherwiseExpand
Higher preablative serum thyroid-stimulating hormone level predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma
Introduction Radioiodine ablation of remnant thyroid tissue is an important adjuvant therapy of differentiated thyroid carcinoma (DTC) after thyroidectomy. Elevated serum thyroid-stimulating hormoneExpand
Correction to: 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study
The author of this article wanted to change the ethical approval statement of the originally published version of this article. Correct statement is indicated below.
First Results and Experience with PRRT in South Africa
Neuroendocrine tumors (NETs) are a diverse group of tumors that often present late due to nonspecific symptoms. These tumors frequently express somatostatin receptors (SSRs), which allows forExpand
Fluorodeoxyglucose Positron Emission Tomography integrated with computed tomography in carcinoma of the cervix: Its impact on accurate staging and the predictive role of its metabolic parameters
Objectives To determine the impact of FDG-PET/CT in the initial staging of cervical cancer among women with and without HIV and to determine the abilities of FDG-PET/CT metabolic parameters inExpand
Diagnostic sensitivity of Tc‐99m HYNIC PSMA SPECT/CT in prostate carcinoma: A comparative analysis with Ga‐68 PSMA PET/CT
Emerging data from published studies are demonstrating the superiority of Ga‐68 PSMA PET/CT imaging in prostate cancer. However, the low yield of the Ge‐68/Ga‐68 from which Gallium‐68 is obtained andExpand